Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 8, Issue 8, pp. 2152-2162
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 31, 2009
- Accepted May 26, 2009
- Published first August 11, 2009.
Article Versions
- Previous version (August 11, 2009 - 08:30).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2009 American Association for Cancer Research.
Author Information
- Doyel Mitra1,
- Michael J. Brumlik2,
- Stella U. Okamgba1,
- Yun Zhu3,
- Tamika T. Duplessis4,
- Jenny G. Parvani1,
- Samuel M. Lesko5,
- Edi Brogi6 and
- Frank E. Jones7
- 1Department of Pathology, University of Colorado-Denver, Aurora, Colorado; 2Cancer Therapy and Research Center, University of Texas Health Center at San Antonio, San Antonio, Texas; Departments of 3Medicine and 4Structural and Cellular Biology, Tulane University Health Sciences Center, New Orleans, Louisiana; 5Northeast Regional Cancer Institute, Scranton, Pennsylvania; 6Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York; and 7Department of Cell and Molecular Biology, Tulane University, New Orleans, Louisiana
- Requests for reprints:
Frank E. Jones, Department of Cell and Molecular Biology, Tulane University, 6400 Freret Street, 2000 Percival Stern Hall, New Orleans, LA, 70118. Phone: 504-862-8081; Fax: 504-865-6785. E-mail: fjones3{at}tulane.edu
August 2009
Volume 8, Issue 8
Volume 8, Issue 8
An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance
Jump to section
Advertisement